Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism
- 21 April 2010
- journal article
- reflection and-reaction
- Published by Elsevier in The Lancet Oncology
- Vol. 11 (6) , 507-509
- https://doi.org/10.1016/s1470-2045(10)70097-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Reestablishing the Researcher-Patient CompactScience, 2007
- The IncidentalomeJAMA, 2006
- Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot FlashesJournal of Clinical Oncology, 2005
- Moving towards individualized medicine with pharmacogenomicsNature, 2004
- A marker for Stevens–Johnson syndromeNature, 2004
- Effects of Computerized Physician Order Entry and Clinical Decision Support Systems on Medication SafetyArchives of internal medicine (1960), 2003
- Inheritance and Drug ResponseNew England Journal of Medicine, 2003
- The Sequence of the Human GenomeScience, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipientThe Lancet, 1993